A semaglutide injection may begin affecting appetite and blood-glucose regulation soon after treatment, while noticeable results can take several weeks. Semanize 4 mg contains semaglutide, a GLP-1 medicine that supports insulin release and helps reduce appetite. Results vary between individuals. For Australian treatment information, dosing guidance, and medicine safety, visit genericshub.com and consult a qualified healthcare professional.
